Thomas S Harrison Selected Research

Thomas S Harrison Research Topics

Disease

58	Cryptococcal Meningitis 06/2022 - 05/2004
13	Infections 10/2020 - 02/2005
8	Cryptococcosis 01/2022 - 05/2004
6	Meningoencephalitis 12/2019 - 02/2010
5	Meningitis 12/2020 - 03/2007
5	Tuberculosis (Tuberculoses) 07/2020 - 02/2010
4	Body Weight (Weight, Body) 01/2022 - 03/2007
3	Mycoses (Diseases, Fungus) 06/2022 - 01/2003
3	HIV Infections (HIV Infection) 10/2020 - 05/2015
3	Aneuploidy (Aneuploid) 12/2019 - 01/2018
3	Immune Reconstitution Inflammatory Syndrome 10/2018 - 06/2010
3	Anemia 01/2018 - 01/2012
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017 - 08/2011
3	Hypokalemia 01/2017 - 01/2012
2	Pulmonary Tuberculosis 01/2019 - 10/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 01/2017
2	Headache (Headaches) 10/2018 - 10/2018
2	Ototoxicity 01/2017 - 08/2011
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 05/2015
2	Neutropenia 12/2015 - 02/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	COVID-19 01/2021
1	Chromosome Duplication 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Fever (Fevers) 10/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2018
1	Hearing Loss (Hearing Impairment) 01/2017
1	Vitamin D Deficiency 08/2014
1	Inflammation (Inflammations) 01/2014
1	Central Nervous System Diseases (CNS Diseases) 01/2013
1	Invasive Fungal Infections 08/2012
1	Aspergillosis 11/2009
1	Mannose-Binding Protein Deficiency 11/2009
1	Vision Disorders (Hemeralopia) 11/2005
1	Bacterial Infections (Bacterial Infection) 02/2005

Drug/Important Bio-Agent (IBA)

27	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 05/2004
18	Flucytosine (Ancobon)FDA Link 01/2022 - 05/2004
17	AntigensIBA 01/2022 - 08/2005
15	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020 - 05/2004
7	liposomal amphotericin B FDA Link 01/2022 - 07/2013
7	Pharmaceutical PreparationsIBA 01/2019 - 05/2004
4	deoxycholate drug combination amphotericin BIBA 01/2022 - 07/2013
3	Antifungal AgentsIBA 06/2022 - 06/2013
3	Capsules (Microcapsules)IBA 01/2018 - 09/2006
3	InterferonsIBA 01/2014 - 06/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 09/2006
2	chinese inkIBA 01/2022 - 10/2018
2	rifapentine (Priftin)FDA Link 01/2019 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2017
2	ElectrolytesIBA 01/2017 - 12/2015
2	Capreomycin (Capastat)FDA Link 01/2017 - 08/2011
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 08/2011
2	CreatinineIBA 12/2015 - 01/2012
2	CytokinesIBA 04/2015 - 02/2005
2	EnzymesIBA 11/2009 - 01/2003
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Macrophage Colony-Stimulating FactorIBA 11/2020
1	lipoarabinomannan (LAM)IBA 07/2020
1	RifamycinsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018
1	CarbonIBA 12/2018
1	dimemorfan (AT 17)IBA 10/2018
1	FluoroquinolonesIBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	ChemokinesIBA 04/2015
1	Genetic Markers (Genetic Marker)IBA 01/2015
1	Moxifloxacin (Avelox)FDA Link 10/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2014
1	Pyrazinamide FDA LinkGeneric 10/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2014
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2014
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	LaccaseIBA 05/2014
1	Interleukin-7 (Interleukin 7)IBA 01/2014
1	InterleukinsIBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 01/2012
1	PotassiumIBA 01/2012
1	Saline SolutionIBA 01/2012
1	LipidsIBA 02/2010
1	Pattern Recognition ReceptorsIBA 11/2009
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2009
1	Complement System Proteins (Complement)IBA 11/2009
1	ImmunosorbentsIBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	Interleukin-10 (Interleukin 10)IBA 03/2007

Therapy/Procedure

43	Therapeutics 06/2022 - 05/2004
5	Art Therapy 10/2021 - 01/2013
3	Immunotherapy 11/2020 - 06/2012
2	Injections 01/2017 - 08/2011
1	Aftercare (After-Treatment) 01/2017
1	Duration of Therapy 01/2017
1	Immunomodulation 04/2015